CALCA and non-small cell lung carcinoma: In another retrospective study consisting of 95 metastatic NSCLC patients who received immune-check point inhibitors, a baseline PCT concentration of > 0.1 mg/L was confirmed to result in significantly worse outcomes in terms of OS [33].